Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use
- PMID: 1382013
- DOI: 10.2165/00003495-199244020-00003
Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use
Abstract
Four new nondepolarising muscle relaxants, pipecuronium bromide, doxacurium chloride, mivacurium chloride and Org 9426 (rocuronium) offer alternatives to the established agents atracurium besilate and vecuronium bromide. Pipecuronium and Org 9426 are steroidal compounds, the latter being a monoquaternary agent, whereas doxacurium and mivacurium are bisquaternary benzylisoquinolinium compounds. Pipecuronium and doxacurium have a relatively slow onset and a long duration of action. Pipecuronium produces maximum block in 3 to 6 min when given in a dose of 45 to 80 micrograms/kg, and a duration of clinical relaxation of between 40 and 110 min. Doxacurium is more potent, but is the least rapid and the longest acting relaxant currently available. When administered in doses of 37 to 80 micrograms/kg, it produces maximum block within 3.5 to 10 min, with a duration of clinical relaxation of 77 to 164 min. The advantage of both pipecuronium and doxacurium is their cardiovascular stability. Both agents are primarily eliminated via the kidneys and both have now been licensed for use in the US. Mivacurium is a muscle relaxant with a short duration of action. When administered in doses of 0.1 to 0.25 mg/kg it produces maximum block in 2 to 4 min, but the duration of clinical relaxation is less than 20 min. Higher doses which could induce a faster neuromuscular block are unfortunately associated with some histamine liberation. The drug is metabolised by plasma cholinesterase. Mivacurium has also been licensed for use in the US. Org 9426 is an agent with a rapid onset but an intermediate duration of action. A dose of 0.5 to 0.6 mg/kg induces maximum block in about 1.5 min and has a duration of clinical relaxation of about 30 min. The rapid onset of effect could be useful for early intubation as an alternative to suxamethonium chloride. However, much more clinical experience is needed with this agent, particularly with regard to duration of action of larger doses and occurrence of side effects. The drug is mainly eliminated via the liver.
Similar articles
-
Newer neuromuscular blocking agents.Pharmacol Toxicol. 1994 Jan;74(1):3-9. doi: 10.1111/j.1600-0773.1994.tb01065.x. Pharmacol Toxicol. 1994. PMID: 8159634 Review.
-
Newer neuromuscular blocking agents: how do they compare with established agents?Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003. Drugs. 2001. PMID: 11434449 Review.
-
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.Clin Pharmacokinet. 1999 Mar;36(3):169-89. doi: 10.2165/00003088-199936030-00001. Clin Pharmacokinet. 1999. PMID: 10223167 Review.
-
Clinical experiences with pipecuronium bromide.Acta Chir Hung. 1983;24(4):207-14. Acta Chir Hung. 1983. PMID: 6322488
-
Interactions between pipecuronium and suxamethonium in the dog.Res Vet Sci. 1987 Nov;43(3):308-12. Res Vet Sci. 1987. PMID: 2832912
Cited by
-
Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.Drugs. 1993 Jun;45(6):1066-1089. doi: 10.2165/00003495-199345060-00009. Drugs. 1993. PMID: 7691494 Review.
-
Anesthesia.J Gen Intern Med. 1994 Nov;9(11):635-47. doi: 10.1007/BF02600309. J Gen Intern Med. 1994. PMID: 7853073 Review. No abstract available.
-
Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium.Can J Anaesth. 1993 Aug;40(8):703-8. doi: 10.1007/BF03009764. Can J Anaesth. 1993. PMID: 8104727 Clinical Trial.
-
Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review.Med Sci Monit. 2025 Jan 1;31:e945822. doi: 10.12659/MSM.945822. Med Sci Monit. 2025. PMID: 39741402 Free PMC article. Review.
-
[Fast-track rehabilitation in colon surgery. Contribution of anesthesia].Anaesthesist. 2007 Jul;56(7):713-25; quiz 726-7. doi: 10.1007/s00101-007-1213-x. Anaesthesist. 2007. PMID: 17607552 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources